People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CiVi Biopharma Holdings, Inc. | — | Biotechnology | Series C | $76.5M | $972.2M | 2020 |
| BioCytics, Inc. | — | Other Health Care | Seed | $1.4M | $11.0M | 2023 |
Matthew Pietras at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Pietras on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shalom Jacobovitz | 1 | 3 |
| Aaron Davis | 1 | 3 |
| Carole Nuechterlein | 1 | 2 |
| John Powderly | 1 | 2 |
| Jim Powderly | 1 | 1 |
| Christopher Fuglesang | 1 | 1 |
| Henrik Oerum | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.